Trial · NCT01576406
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Normal Hepatic Function: Crizotinib 250 mg Twice Daily | 11 | |
| Overall Study | STARTED | Normal Hepatic Function: Crizotinib 200/250 mg Twice Daily | 15 | |
| Overall Study | STARTED | Mild Hepatic Impairment: Crizotinib 250 mg Twice Daily | 20 | |
| Overall Study | STARTED | Moderate Hepatic Impairment: Crizotinib 250 mg Once Daily | 10 | |
| Overall Study | STARTED | Moderate Hepatic Impairment Crizotinib 200 mg Twice Daily | 16 | |
| Overall Study | STARTED | Severe Hepatic Impairment Crizotinib 250 mg Once Daily | 16 | |
| Overall Study | COMPLETED | Normal Hepatic Function: Crizotinib 250 mg Twice Daily | 5 | |
| Overall Study | COMPLETED | Normal Hepatic Function: Crizotinib 200/250 mg Twice Daily | 7 | |
| Overall Study | COMPLETED | Mild Hepatic Impairment: Crizotinib 250 mg Twice Daily | 4 | |
| Overall Study | COMPLETED | Moderate Hepatic Impairment: Crizotinib 250 mg Once Daily | 1 | |
| Overall Study | COMPLETED | Moderate Hepatic Impairment Crizotinib 200 mg Twice Daily | 8 | |
| Overall Study | COMPLETED | Severe Hepatic Impairment Crizotinib 250 mg Once Daily | 4 | |
| Overall Study | NOT COMPLETED | Normal Hepatic Function: Crizotinib 250 mg Twice Daily | 6 | |
| Overall Study | NOT COMPLETED | Normal Hepatic Function: Crizotinib 200/250 mg Twice Daily | 8 | |
| Overall Study | NOT COMPLETED | Mild Hepatic Impairment: Crizotinib 250 mg Twice Daily | 16 | |
| Overall Study | NOT COMPLETED | Moderate Hepatic Impairment: Crizotinib 250 mg Once Daily | 9 | |
| Overall Study | NOT COMPLETED | Moderate Hepatic Impairment Crizotinib 200 mg Twice Daily | 8 | |
| Overall Study | NOT COMPLETED | Severe Hepatic Impairment Crizotinib 250 mg Once Daily | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01576406/flow